Vireo Expands PA Cannabis
Vireo Growth Inc. Completes $20 Million Acquisition of Pennsylvania Cannabis Dispensary License
Anonymous
Vireo Growth Inc. (CSE: VREO) has closed its acquisition of FarmX, LLC, doing business as PhytoNatural, along with joint venture partner Vive Penn, LLC, according to Leader Post. The deal gives Vireo a Pennsylvania medical cannabis retail permit that allows the operation of up to six dispensaries in the state.
The total price tag was $20.0 million. Vireo paid $8.0 million in cash at closing and issued roughly 645,161 subordinate voting shares worth approximately $12.0 million, Montreal Gazette reported. Vireo now operates in 10 states with more than 170 dispensaries nationwide.
A $20 Million Bet on Pennsylvania's Cannabis Market
Vireo bought all membership interests in FarmX, LLC from its owners. The deal was done jointly with Vive Penn, LLC, a joint venture between Vireo and Hive Holdings, Inc., Calgary Sun reported. The acquired permit is currently non-operational, meaning no dispensaries are open yet under this license.
The permit is significant. Pennsylvania law allows a single retail permit holder to run up to six dispensary locations. That gives Vireo room to build a meaningful retail footprint in the state from a single license, according to Chatham Daily News.
Stock and Cash Split Funds the Pennsylvania Push
Vireo structured the deal with a mix of cash and stock. Of the $20.0 million total, $8.0 million was paid in cash at closing. The rest — about $12.0 million — came in the form of roughly 645,161 newly issued Vireo subordinate voting shares, Daily Herald Tribune reported.
Using stock as part of the payment lets Vireo preserve cash while still completing a major deal. It also ties the sellers to the company's future performance. If Vireo's share price rises, both sides benefit, according to Pembroke Observer.
Vireo Eyes Bigger Footprint Across 10 States
Vireo already runs more than 170 dispensaries across 10 states. The company has been focused on growing its market share and building out its consumer brand portfolio, Northern News reported. The Pennsylvania deal fits that broader expansion strategy.
Pennsylvania is one of the larger medical cannabis markets in the United States. Getting a permit that covers up to six locations gives Vireo a real entry point. The company will need to activate the non-operational license to start serving patients, according to Stratford Beacon Herald.
Joint Venture Structure Ties Vireo to Hive Holdings
The acquisition was completed jointly through Vive Penn, LLC. That entity is a joint venture between Vireo and Hive Holdings, Inc. Structuring the deal through a joint venture is a common way to share risk and pool resources on large cannabis license transactions, Fort Saskatchewan Record reported.
Vireo trades on the Canadian Securities Exchange under the ticker VREO. The company has been active in building its U.S. cannabis presence through acquisitions. This Pennsylvania permit adds a new state-level asset to its growing portfolio, according to Whitecourt Star.
Sentiment
NeutralNEGATIVENEUTRALPOSITIVE
Publishers
24
Articles
24
Reach
24
A
AnonymousAuthor